The boom of Sildenafil initially drove significant growth in the medicinal sector, generating a understanding of easy profits. However, investing in companies solely reliant on top-selling drugs like the erectile https://saulgdwg902759.yomoblog.com/48402720/the-blue-pill-and-big-pharma-a-hazardous-investment